Güle Çınar
Impact in
-
- Antibiotic Use and Resistance
-
- Antifungal resistance and susceptibility
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
- Epidemiology 11
- Hepatitis B Virus Studies 5
- Liver Disease Diagnosis and Treatment 4
-
- SARS-CoV-2 and COVID-19 Research 4
- COVID-19 Clinical Research Studies 3
- Antifungal resistance and susceptibility 2
- Co-authors
- İrem Akdemir Kalkan (16 shared papers)Alpay Azap (10 shared papers)Füsun Can (2 shared papers)Deniz Balcı (2 shared papers)Zeynep Ceren Karahan (2 shared papers)Şiran Keske (2 shared papers)Süda Tekin (2 shared papers)Nazlı Ataç (1 shared paper)
- Journals
- Frontiers in Psychiatry (1 paper)Immunogenetics (1 paper)International Journal of Clinical Practice (1 paper)International Journal of Antimicrobial Agents (1 paper)Clinical Microbiology and Infection (1 paper)
- Partner nations
- TürkiyeUnited StatesUnited Kingdom
In The Last Decade
Güle Çınar
19 papers receiving 84 citations
Peers
Comparison fields: 5 of 48
- Applied Microbiology and Biotechnology 7
- Infectious Diseases 35
- Molecular Medicine 6
- Geriatrics and Gerontology 3
- Epidemiology 20
Countries citing papers authored by Güle Çınar
This map shows the geographic impact of Güle Çınar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Güle Çınar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Güle Çınar more than expected).
Fields of papers citing papers by Güle Çınar
This network shows the impact of papers produced by Güle Çınar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Güle Çınar. The network helps show where Güle Çınar may publish in the future.
Co-authors
The 25 scholars most cited alongside Güle Çınar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 23 | |
| 2 | 2021 | 11 | |
| 3 | 2019 | 10 | |
| 4 | 2020 | 6 | |
| 5 | 2023 | 5 | |
| 6 | 2022 | 4 | |
| 7 | 2023 | 4 | |
| 8 | 2021 | 4 | |
| 9 | 2023 | 3 | |
| 10 | 2021 | 2 | |
| 11 | 2019 | 2 | |
| 12 | 2021 | 2 | |
| 13 | Tıp Fakültesi birinci sınıf öğrencilerinin madde bağımlılığı ile ilgili bilgi, görüş ve tutumları | 2004 | 2 |
| 14 | 2020 | 1 | |
| 15 | 2020 | 1 | |
| 16 | 2020 | 1 | |
| 17 | 2019 | 1 | |
| 18 | 2021 | 1 | |
| 19 | 2020 | 1 | |
| 20 | 2025 | 0 |
About Güle Çınar
Güle Çınar is a scholar working on Epidemiology, Infectious Diseases, Hepatology, Neurology and Applied Microbiology and Biotechnology, having authored 29 papers that have together received 84 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (5 papers), Hepatitis C virus research (5 papers), Liver Disease Diagnosis and Treatment (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Long-Term Effects of COVID-19 (4 papers), Antibiotic Use and Resistance (3 papers), COVID-19 Clinical Research Studies (3 papers) and Antifungal resistance and susceptibility (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (7 citations), Infectious Diseases (35 citations), Molecular Medicine (6 citations), Geriatrics and Gerontology (3 citations) and Epidemiology (20 citations). Güle Çınar has collaborated with scholars based in Türkiye, United States and United Kingdom. Frequent co-authors include İrem Akdemir Kalkan, Alpay Azap, Füsun Can, Deniz Balcı, Zeynep Ceren Karahan, Şiran Keske, Süda Tekin, Nazlı Ataç, Necati Örmecı and Akın Kaya. Their work appears in journals such as Frontiers in Psychiatry, Immunogenetics, International Journal of Clinical Practice, International Journal of Antimicrobial Agents and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.